US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Frequency Therapeutics Inc (FREQ)
Frequency Therapeutics Inc (FREQ) ニュース

FREQ

Frequency Therapeutics (FREQ)

Frequency Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:FREQ

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/02	06 : 18	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:FREQ	Frequency Therapeutics Inc
2024/04/29	20 : 47	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:FREQ	Frequency Therapeutics Inc
2024/04/29	20 : 44	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:FREQ	Frequency Therapeutics Inc
2024/04/29	20 : 42	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:FREQ	Frequency Therapeutics Inc
2024/04/27	05 : 01	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:FREQ	Frequency Therapeutics Inc
2024/04/25	08 : 33	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:FREQ	Frequency Therapeutics Inc
2024/04/25	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FREQ	Frequency Therapeutics Inc
2024/04/25	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FREQ	Frequency Therapeutics Inc
2024/04/25	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FREQ	Frequency Therapeutics Inc
2024/04/24	06 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FREQ	Frequency Therapeutics Inc
2024/04/23	06 : 14	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:FREQ	Frequency Therapeutics Inc
2024/04/23	06 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FREQ	Frequency Therapeutics Inc
2024/04/20	05 : 06	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:FREQ	Frequency Therapeutics Inc
2024/04/18	21 : 52	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:FREQ	Frequency Therapeutics Inc
2024/04/18	21 : 40	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FREQ	Frequency Therapeutics Inc
2024/03/29	04 : 20	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:FREQ	Frequency Therapeutics Inc
2024/03/28	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:FREQ	Frequency Therapeutics Inc
2024/03/27	06 : 09	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:FREQ	Frequency Therapeutics Inc
2024/03/27	06 : 03	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:FREQ	Frequency Therapeutics Inc
2024/03/27	05 : 14	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FREQ	Frequency Therapeutics Inc
2024/03/27	05 : 02	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:FREQ	Frequency Therapeutics Inc
2023/11/07	07 : 24	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:FREQ	Frequency Therapeutics Inc
2023/11/07	07 : 22	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:FREQ	Frequency Therapeutics Inc
2023/11/06	22 : 51	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FREQ	Frequency Therapeutics Inc
2023/11/03	05 : 05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FREQ	Frequency Therapeutics Inc
2023/10/26	05 : 01	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:FREQ	Frequency Therapeutics Inc
2023/10/13	05 : 05	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:FREQ	Frequency Therapeutics Inc
2023/10/02	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:FREQ	Frequency Therapeutics Inc
2023/09/30	05 : 14	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:FREQ	Frequency Therapeutics Inc
2023/09/28	19 : 06	Edgar (US Regulatory)	Form S-4/A - Registration of securities, business combinations: [Amend]	NASDAQ:FREQ	Frequency Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:FREQ

1 2 3 4 5 6 7 8 9 10 次へ >>

BPCE 0.192% until 24/06/...

Technovative (GM)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約